Data Characteristics
Data for hematologic oncology clinical trial pre-screening originates from medical literature (e.g., PubMed, ASCO conference abstracts), clinical trial registries (e.g., ClinicalTrials.gov), structured and unstructured electronic health record (EHR) data, and genomic/proteomic reports. Data updates frequently, with new publications and ongoing trials continuously adding information. Document structures typically follow standard medical paper formats, including title, abstract, introduction, methods, results, and discussion. Clinical trial protocols detail inclusion/exclusion criteria, treatment regimens, and endpoint indicators. Fields and units are highly specialized, for example, "complete remission (CR)," "partial remission (PR)," "minimal residual disease (MRD) positive," "chromosomal karyotype abnormality t(9;22)." This involves disease staging, gene mutation types, treatment drug dosages (e.g., mg/kg), and treatment cycles (e.g., cycles).
Constraints on Vector Models and Indexing
The specialized nature and high update frequency of hematologic oncology data impose specific requirements on vector models and indexing. First, numerous specialized terms and abbreviations demand that vector models possess strong semantic understanding. They must differentiate the exact meaning of similar terms in varying contexts, for instance, distinguishing "AML" as acute myeloid leukemia from other abbreviations. High-frequency updates require an efficient incremental update mechanism for the indexing system. This ensures that the latest trial data and research progress are promptly incorporated into the knowledge base, preventing information lag. Complex document structures, including numerous tables, graphical descriptions, and unstructured text, necessitate fine-grained text segmentation strategies to maintain the integrity of critical information units. Furthermore, precise matching of key fields like disease staging, gene mutations, and treatment regimens is crucial for pre-screening results. This requires vector retrieval to combine keyword or entity recognition with semantic similarity.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size | 500–700 characters | Clinical trial documents and medical literature often contain dense information blocks. This length helps maintain contextual completeness and avoids key information being fragmented. |
Chunk overlap | 50–100 characters | Sufficient overlap between segments captures semantic connections across paragraphs, especially when processing itemized descriptions like inclusion/exclusion criteria. |
Recall count | 10–20 entries | Hematologic oncology trial enrollment conditions are often complex and multi-dimensional. Increasing recall items improves coverage and avoids missing potentially eligible patient information. |
Similarity threshold | Calibrate by measurement | This requires iterative testing with a small batch of labeled data, based on the specific dataset's semantic distribution and business needs, to balance recall precision and recall rate. |
Rerank result count | 5–8 entries | Clinical pre-screening ultimately requires precise matching of a few core conditions. Reranking helps bring the most relevant results to the forefront for manual review. |
maxContext | 3000–4000 token | Given the detailed nature of hematologic oncology reports, a larger context window better supports the model's understanding of complex medical descriptions and multi-condition judgments. |
Common Pitfalls
- Symptom: Retrieval results contain many document fragments irrelevant to the query topic. Reason:
Chunk sizeis set too long, causing a single vector to contain excessive irrelevant information and dilute the core semantics. - Symptom: Newly published clinical trial information cannot be retrieved promptly. Reason: The knowledge base's incremental update mechanism is not effectively configured or executed, leading to the index not syncing the latest data.
- Symptom: Precise matching for specific gene mutations or drug names fails. Reason: The vector model is not fine-tuned for specific domain vocabulary, resulting in inaccurate embedded representations of specialized terms and insufficient semantic generalization.
Validation Steps
- Select a representative set of hematologic oncology clinical trial queries. Check if the recall results include all known relevant document fragments.
- Compare the latest data in the knowledge base with actual retrieval results. Verify if newly added literature and trials are indexed and recalled within a reasonable timeframe.
- Simulate queries using patient information with known inclusion/exclusion criteria. Verify if the returned results accurately match or exclude these patients. Adjust
Similarity thresholdbased on business needs. - Check the FastGPT backend's knowledge base status for any warnings about indexing failures or update delays.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.